World's Best Scientists 2026 revealed!
Kazimiera J. Gajl-Peczalska

Kazimiera J. Gajl-Peczalska

D-Index & Metrics

Biology and Biochemistry

D-Index
50
Citations
9573
World Ranking
17594
National Ranking
7217

Kazimiera J. Gajl-Peczalska publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Kazimiera J. Gajl-Peczalska sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 90 publications — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Kazimiera J. Gajl-Peczalska D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Kazimiera J. Gajl-Peczalska sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 50 D-Index — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Kazimiera J. Gajl-Peczalska is affiliated with the University of Minnesota in the United States.

Currently, there is no publicly available information regarding recent papers, frequent co-authors, main or subfields of study, main topics of work, publication venues, or book publications related to this scientist.

There is also no data on awards or recognitions received.

This profile is based solely on verified affiliation details without additional insights into research focus or professional contributions at this time.

Best Publications

  • Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation.

    D. W. Hanto;G. Frizzera;K. J. Gajl-Peczalska;K. Sakamoto

  • Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation.

    RS Shapiro;K McClain;G Frizzera;KJ Gajl-Peczalska

  • Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

    Douglas W. Hanto;Kazimiera J. Gajl-peczalska;Glauco Frizzera;Diane C. Arthur

  • Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients.

    Glauco Frizzera;Douglas W. Hanto;Kazimiera J. Gajl-Peczalska;Juan Rosai

  • Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation.

    Douglas W. Hanto;Glauco Frizzera;Kazimiera J. Gajl-Peczalska;Richard L. Simmons

  • Nonrandom Chromosome Abnormalities in Lymphoma

    Clara D. Bloomfield;Diane C. Arthur;Glauco Frizzera;Ellis G. Levine

  • Characterization of a leukemic cell line of the pre‐B phenotype

    Richard Hurwitz;Richard Hurwitz;John Hozier;John Hozier;Tucker W LeBien;Tucker W LeBien;Jun Minowada;Jun Minowada

  • Clinical characteristics of post-transplant lymphoproliferative disorders

    Vicki A. Morrison;David L. Dunn;J.Carlos Manivel;K.J. Gajl-Peczalska

  • Detailed Studies on Expression and Function of CD19 Surface Determinant by Using B43 Monoclonal Antibody and the Clinical Potential of Anti-CD19 Immunotoxins

    Fatih M. Uckun;Waclaw Jaszcz;Julian L. Ambrus;Anthony S. Fauci

  • Chronic lymphoproliterative disorder with unusual clinical, morphologic, ultrastructural and membrane surface marker characteristics

    Robert W. McKenna;Janet Parkin;John H. Kersey;Kazimiera J. Gajl-Peczalska

  • Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells.

    Fatih M. Uckun;Kazimiera Gajl-Peczalska;Dorothea E. Myers;Waclaw Jaszcz

  • Acute Lymphoblastic Leukemic Cells with T (Thymus-Derived) Lymphocyte Markers

    John H. Kersey;Andrej Sabad;Kazimiera Gajl-Peczalska;Helen M. Hallgren

  • B and T cell lymphomas: Analysis of blood and lymph nodes in 87 patients

    Kazimiera J. Gajl-Peczalska;Clara D. Bloomfield;Peter F. Coccia;Henry Sosin

  • Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia.

    Fatih M. Uckun;Kazimiera J. Gajl-Peczalska;John H. Kersey;Lou L. Houston

  • Clinical utility of lymphocyte surface markers combined with the Lukes-Collins histologic classification in adult lymphoma.

    Clara D. Bloomfield;Kazimiera J. Gajl-Peczalska;Glauco Frizzera;John H. Kersey

  • B and T Lymphocytes in Primary Immunodeficiency Disease in Man

    Kazimiera J. Gajl-Peczalska;Byung H. Park;W. Douglas Biggar;Robert A. Good

  • Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues.

    Fatih M. Uckun;Atsushi Muraguchi;Jeffrey A. Ledbetter;Tadamitsu Kishimoto

  • Epstein–Barr Virus-Induced B-Cell Lymphoma after Renal Transplantation

    Stephen H. Leech;Prem Kumar;Douglas W. Hanto;Glauco Frizzera

  • Confirmation of the heterogeneity of posttransplant Epstein-Barr virus-associated B cell proliferations by immunoglobulin gene rearrangement analyses.

    Douglas W. Hanto;Mark P Birkenbach;Glauco Frizzera;Kazimiera J. Gajl-Peczalska

  • Four new recurring translocations in non-Hodgkin lymphoma

    Ellis G. Levine;Diane C. Arthur;Joy Machnicki;Glauco Frizzera

Frequent Co-Authors

John H. Kersey
John H. Kersey University of Minnesota
Clara D. Bloomfield
Clara D. Bloomfield The Ohio State University
Richard D. Brunning
Richard D. Brunning University of Minnesota
Diane C. Arthur
Diane C. Arthur National Institutes of Health
Fatih M. Uckun
Fatih M. Uckun University of Southern California
Tucker W. LeBien
Tucker W. LeBien University of Minnesota
Robert A. Good
Robert A. Good University of Minnesota
Mark E. Nesbit
Mark E. Nesbit University of Minnesota
Norma K.C. Ramsay
Norma K.C. Ramsay University of Minnesota
Henry H. Balfour
Henry H. Balfour University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees opens exciting options for students in Biology and Biochemistry. Many graduates consider fields that blend science with healthcare administration, such as pursuing the cheapest online MBA in healthcare management. This pathway can lead to advanced roles in hospitals and research organizations.

Another promising area is medical coding and billing—an in-demand field vital to healthcare operations. If you're curious about certifications, it's smart to compare ccs vs cpc salary details. These credentials can affect your earning potential and job opportunities.

Students often want to know: what can you expect to earn? According to insights about medical.coder salary, this career offers solid income and stability, especially with specialized training.

The job outlook for medical billing and coding remains strong as healthcare continues to expand. Online degrees make entering and progressing in this career more accessible for science graduates seeking flexible, rewarding options.

Best Scientists Citing Kazimiera J. Gajl-Peczalska

Recently Published Articles